96 related articles for article (PubMed ID: 8961046)
1. The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens.
Otsuki M; Nishino T
J Antimicrob Chemother; 1996 Nov; 38(5):771-6. PubMed ID: 8961046
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
Mayer I; Nagy E
J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886
[TBL] [Abstract][Full Text] [Related]
3. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
4. Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens.
Lewin CS; Smith JT
J Med Microbiol; 1990 Jul; 32(3):211-4. PubMed ID: 2165168
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
Dembry LM; Farrel PA; Orcutt DR; Gerrity LA; Andriole VT
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():35-42. PubMed ID: 9222068
[TBL] [Abstract][Full Text] [Related]
6. In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin.
Gould IM; Milne K
J Antimicrob Chemother; 1997 Jan; 39(1):53-61. PubMed ID: 9044028
[TBL] [Abstract][Full Text] [Related]
7. [In vitro synergistic effects of tazobactam/piperacillin with various antibiotics].
Nishida K; Niidome K; Hashimoto M; Otsuki M; Nishino T
Jpn J Antibiot; 1994 Oct; 47(10):1348-62. PubMed ID: 7807695
[TBL] [Abstract][Full Text] [Related]
8. [Effect of subinhibitory levels of aminoglycosides and fluoroquinolines on hydrophobicity and motility of Serratia marcescens].
Majtán V; Majtánová L
Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):26-30. PubMed ID: 11233670
[TBL] [Abstract][Full Text] [Related]
9. Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens.
Berlanga M; Viñas M
J Antimicrob Chemother; 2000 Aug; 46(2):279-82. PubMed ID: 10933653
[TBL] [Abstract][Full Text] [Related]
10. [Bactericidal activity of the complement and its synergistic effects with cephem antibiotics against Serratia marcescens].
Kiyota H; Onodera S; Kishimoto K; Goto H; Machida T; Yokota T
Nihon Hinyokika Gakkai Zasshi; 1988 May; 79(5):910-7. PubMed ID: 3070107
[No Abstract] [Full Text] [Related]
11. Effect of suprainhibitory concentrations of quinolones on hydrophobicity and motility of Serratia marcescens.
Majtán V; Majtánová L
Microbios; 2000; 102(402):79-88. PubMed ID: 10885498
[TBL] [Abstract][Full Text] [Related]
12. Effect of combination of cefsulodin and beta-lactam antibiotics against Serratia marcescens.
Kondo M; Tsuchiya K
J Antibiot (Tokyo); 1981 Oct; 34(10):1327-33. PubMed ID: 7031032
[TBL] [Abstract][Full Text] [Related]
13. [An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
Kumagai K; Otsuki H; Nishibuchi M; Takeda Y
Jpn J Antibiot; 1990 Sep; 43(9):1579-87. PubMed ID: 2124634
[TBL] [Abstract][Full Text] [Related]
14. Post-antibiotic and synergic effects of fluoroquinolones and ceftazidime in combination against Pseudomonas strains.
Mayer I; Nagy E
Acta Biol Hung; 2001; 52(2-3):241-8. PubMed ID: 11426858
[TBL] [Abstract][Full Text] [Related]
15. [In vitro antibacterial activity of piperacillin/quinolone combinations].
Soussy CJ; Leclercq R; Duval J
Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
Matsuzaki K; Yoshimori K; Shikano M; Watabe E; Sato Y; Hasegawa M; Kobayashi I; Yamanaka N
Jpn J Antibiot; 2003 Jun; 56(3):171-9. PubMed ID: 12942788
[TBL] [Abstract][Full Text] [Related]
17. [Bactericidal activity of ciprofloxacin and sparfloxacin. Comparison with others active antibiotics against Pasteurella multocida].
Gastine C; Donnio PY; Travert MF; Avril JL
Presse Med; 1995 Mar; 24(11):519-22. PubMed ID: 7770389
[TBL] [Abstract][Full Text] [Related]
18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ofloxacin, ciprofloxacin, and cefoperazone alone and in combination against Xanthomonas maltophilia.
Ristow TA; Peterson LR; Kahn JB
Drugs; 1995; 49 Suppl 2():246-9. PubMed ID: 8549319
[No Abstract] [Full Text] [Related]
20. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
Chin NX; Neu HC
Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
